课题基金 / 基金详情

Microbiome-based diagnosis of pneumonia in the acute respiratory distress syndrome

Microbiome-based diagnosis of pneumonia in the acute respiratory distress syndrome
基于微生物组的急性呼吸窘迫综合征肺炎诊断
批准号:
10321637
负责人:
Georgios Kitsios
金额:
$16.19万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-01-22 至 2022-12-31
关键词:
16S ribosomal RNA sequencingAccountingAcute Lung InjuryAcute Respiratory Distress SyndromeAddressAdmission activityAdvisory CommitteesAntibiotic ResistanceAntibioticsAntimicrobial susceptibilityBioinformaticsCaringCategoriesClinicalClinical ResearchClinical TrialsClinical Trials DesignCommunitiesComputational BiologyCritical CareCritical IllnessCulture TechniquesDNADNA analysisDNA sequencingDataDevelopmentDiagnosisDiagnosticEcologyEtiologyFutureGenesGoalsHourHypersensitivityImmune responseIndividualInfectionInflammationInflammatoryInflammatory ResponseInfrastructureInjuryIntensive Care UnitsInterleukin-6K-Series Research Career ProgramsLaboratoriesLeadLower respiratory tract structureLungMechanical ventilationMedicineMentored Patient-Oriented Research Career Development AwardMentorsMentorshipMethodsMicrobiologyModernizationOrganismPathogen detectionPatientsPatternPhysiciansPneumoniaPositioning AttributeProspective cohort studyPublic HealthRegimenResearchResearch DesignSamplingScientistSensitivity and SpecificityTechniquesTimeTrainingUniversitiesValidationWorkaccurate diagnosisadvanced analyticsantimicrobialbacterial communitybasebiobankcareer developmentclinical sequencingcohortcost effectivenessdesigndiagnostic tooleffective therapyeffectiveness outcomeemerging antimicrobial resistanceexperiencegenome sequencinghuman microbiotaimprovedindexingindividual patientinfection managementinflammatory markerinnovationlung injurylung microbiomemicrobialmicrobial communitymicrobiomemicrobiome researchmicrobiotamicrobiota profilesmortalitymortality risknanoporenext generation sequencingnovelpathogenpersonalized managementpoint of careprocalcitoninprospectivereceptor for advanced glycation endproductsstandard of caretechnique developmenttraining opportunitytranslational physiciantranslational scientisttranslational studywhole genome

项目摘要

项目成果

Georgios Kitsios的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
PROJECT ABSTRACT This application is for a Mentored Patient-Oriented Research Career Development Award entitled “Microbiome-based diagnosis of pneumonia in the acute respiratory distress syndrome”. I am a Pulmonary and Critical Care Medicine Fellow at the University of Pittsburgh and I require additional training to develop expertise as a translational researcher in the microbiome of critical illness. The central objective of my research is to utilize emerging microbial DNA sequencing techniques for faster and more accurate diagnosis of pneumonia in critically-ill patients. The focus of my research is the acute respiratory distress syndrome (ARDS), a serious form of inflammatory lung injury often caused by pneumonia and accounting for 10% of intensive care unit admissions in the US with 40% mortality. With diagnostic limitations of the current standard- of-care of microbial cultures, patients often receive empiric, broad-spectrum antibiotics that can be inappropriate or inadequate for their individual needs, and also promote antibiotic resistance – a major public health threat. My preliminary data demonstrate feasibility and proof-of-concept that sequencing of microbial DNA directly from patient samples can lead to faster and more accurate diagnosis of pneumonia compared to cultures. The aims of the study are to develop sequencing-based definitions for pneumonia in (1) culture- positive and (2) culture-negative patients by integrating microbiome and host response data, and then 3) to assess the anticipated impact of sequencing on antibiotic selection. I will execute a prospective cohort study in patients with ARDS and use modern culture-independent sequencing techniques and computational biology methods to study the lung microbiome in relation to host-responses and microbiologic cultures. The proposed sequencing-based approach has the potential to improve accuracy of pneumonia diagnosis (capturing both cultivable and non-cultivable organisms) and to provide information to clinicians much faster than cultures. Thus, my proposal addresses a high priority issue for development of innovative diagnostics of infections to improve antibiotic usage and provides a unique translational training opportunity. I propose a research- intensive period of career development with hands-on and didactic training in advanced sequencing techniques, bioinformatics, computational biology and clinical trial design and implementation. The work will be conducted within the Division of Pulmonary, Allergy, and Critical Care Medicine at the University of Pittsburgh, which has an outstanding record of training physician-scientists and a highly-developed infrastructure for the conduct of translational studies. I am supported by a committed mentoring partnership with convergent expertise in microbiome and critical care research, and a diverse Mentoring Advisory Committee. With support from the K23 Mentored Career Development Award, I will develop an independent project examining sequencing-based pneumonia diagnostics for an R01 proposal over the next five years.
期刊论文(27)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1136/bmjopen-2022-066626
发表时间: 2023-01-12
期刊: BMJ open
影响因子: 2.9
作者: []
通讯作者:
Protecting the lungs but hurting the kidneys: causal inference study for the risk of ventilation-induced kidney injury in ARDS.
保护肺部但伤害肾脏:ARDS 通气诱发肾损伤风险的因果推断研究。
DOI: 10.21037/atm-20-2050
发表时间: 2020
期刊: Annals of translational medicine
影响因子: --
作者: [Yang,Haopu, Benos,PanayiotisV, Kitsios,GeorgiosD]
通讯作者: Kitsios,GeorgiosD
DOI: 10.1097/cce.0000000000000550
发表时间: 2021-10
期刊: Critical care explorations
影响因子: --
作者: [Shah FA, Kitsios GD, Yende S, Dunlap DG, Scholl D, Chuan B, Al-Yousif N, Zhang Y, Nouraie SM, Morris A, Huang DT, O'Donnell CP, McVerry BJ]
通讯作者: McVerry BJ
DOI: 10.1136/thoraxjnl-2021-217526
发表时间: 2023-04
期刊: Thorax
影响因子: 10
作者: []
通讯作者:
15
    Microbial Determinants of Acute Respiratory Distress Syndrome Severity (MiDAS)
    Microbial Determinants of Acute Respiratory Distress Syndrome Severity (MiDAS)
    Microbiome-based diagnosis of pneumonia in the acute respiratory distress syndrome
    海外基金